Cosmetic Wholesaler Warned For Drug Claims On Nonmonograph Ingredients
This article was originally published in The Rose Sheet
Executive Summary
FDA’s letter to Essential Wholesale – one of two warnings issued to cosmetics firms in November – highlights claims for nonmonograph active ingredients that render the firm’s offerings drugs under federal food and drug law, according to the agency. The letter followed an inspection of the company’s manufacturing facility in April 2014 and subsequent review of its website.